Back to results
US 2025/0375543 A1Published application
Oligonucleotide-based therapeutics and uses thereof
OwnerTod Speerinventor
Life of this patent
Estimating the term…
Abstract
Described herein are compounds that are useful for delivering therapeutic, diagnostic, and imaging agents. Also described herein are pharmaceutical compositions containing such compounds and methods of using the compounds and compositions. Also described are processes for manufacture of the compounds and the compositions containing them.
Claims20
A compound of the Formula (V):
- or a pharmaceutically acceptable salt thereof,
- wherein:
- X2 is a chelating agent-selected from EDTA, DTPA, DOTA, TETA, NOTA, Cyclam, PCBA, DADT, and MAMA;
- L1 is a linker group;
- L5 is a linker group or a bond, wherein L1 and L5 can be the same or different, wherein L1 and/or L5 has a chain length of from 1 to 40 atoms;
- T is a click-chemistry-derived core;
- G1 is a single-stranded nucleotide sequence for binding a forward primer;
- Q is a randomized single-stranded DNA;
- G2 is a single-stranded nucleotide sequence for binding a reverse primer wherein the click-chemistry-derived core is (i) a triazole, (ii) an oxazole, (iii) a heterocycle derivable from electrocyclization chemistry, or (iv) selected from one of the following formula:
- wherein Rb is H, alkyl, arylalkyl, -alkyl-S-alkyl or arylalkyl or the side-chain of any naturally- or non-naturally occurring amino acid;
- and
- wherein the compound of the formula (V) is internalized into at least one of the cytoplasm and the nucleus of cancer cells.
9 more elements
Dependencies are inferred from the claim text.